Showing results (1091-1100 of 1,320) with videos related to

Sort By:
Pageof 132
Materials (Basel, Switzerland)|October 21, 2020
XANES Measurements for Studies of Adsorbed Protein Layers at Liquid InterfacesOleg V Konovalov, Natalia N Novikova, Mikhail V Kovalchuk, et al.
Carcinogenesis|March 19, 2026
Role of P450 enzymes of the Cyp2abfgs gene subfamilies in tobacco smoke-induced lung tumorigenesis in miceLisa M Tran, Patricia C Edwards, Weizhu Yang, et al.
Experimental Hematology|March 20, 2026
From Image to Insight: Optimized Multiplex Staining Panel for FFPE Mouse Bone Marrow Enables Spatial Profiling of the Hematopoietic NicheFranziska Zell, Katharina Gellrich, Albert Gründer, et al.
Practical Radiation Oncology|November 27, 2014
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancerKristina Mirabeau-Beale, Theodore S Hong, Andrzej Niemierko, et al.
Annals of Hematology|December 25, 2019
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL studyLuigi Rigacci, Benedetta Puccini, Alessandro Broccoli, et al.
Oncotarget|October 10, 2014
Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathwaysKsenia Lezhnina, Olga Kovalchuk, Alexander A Zhavoronkov, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 14, 2024
Detection of carbapenemase producing Acinetobacter baumannii ST19 from Georgia and Ukraine carrying bla OXA-23, bla OXA-72, and/or bla NDM-5, December 2019 to June 2023Ting L Luo, Melissa J Martin, Valentyn Kovalchuk, et al.
Oncotarget|February 14, 2018
Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiationMaxim Sorokin, Roman Kholodenko, Anna Grekhova, et al.
Scientific Reports|December 21, 2017
ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cellsHongsheng Wang, Ines Gonzalez-Garcia, Javier Traba, et al.
Hematological Oncology|May 25, 2022
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, et al.
Pageof 132